Lead (Pb) poisoning has numerous effects on the erythropoietic system, but the precise mechanism whereby high dose eposure causes anemia is not entirely dear. We previously reported that Pb eposure is associated with depressed serum erythropoietin (EPO) in prgnat women residin in a Pb mining town and in a nonexposed town in Kosovo, Yugoslavia. In a prospective study, we tested the hypothesis that blood Pb concentration (BPb) may be associated with depressed EPO in children. BPb, hemoglobin (Hgb), and serum EPO were measured at ages 4.5, 6.5. and 9.5 years in 211, 178, and 234 children, respectively. At 4.5 years of age, mean BPbs were 38.9 and 9.0 p/dl in the exposed and nonexposed towns, respectiveldy BPbs gradually dedined to 28.2 and 6.5 pg/dl, respectively, by age 9.5 years. No differences were found in Hgb at any age. At age 4.5 yeas, a positive asociation between BPb and EPO (( m 0.21; p -0.0001), controlled for Hgb, was found. The magnitude of this asociaion declined to 0.11 at age 6.5 years (p = 0.0103) and 0.03 at age 9.5 years (p = 0.39). These results were confirmed using repeated measures analyses. We concluded that in Pb-exposed children, the maintenance of normd Hgb requires hyperproduction of EPO. With advancing age (and coninuing exposure), this compensatory mechanism appears to be failing, suggesting a gradual loss of renal endocrine function due to Pb exposure. Key work erythropoietin, hematopoiesis, lead, red cel survival.
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Environ Healtb Pmpect 106:361-364 (1998). [Online 15 May 1998] htp:/lehpnetl.niebs.nib.govldos/19981106p361-364factor-litwak/abstrac.ttml High dose environmental lead (Pb) exposure induces anemia (1) (2) (3) , the mechanism of which is not entirely clear. Elevated blood lead concentrations (BPbs) are associated with impaired heme synthesis (46), but even in severe Pb intoxication, elevated BPbs alone cannot account for the decrement in hemoglobin (Hgb) synthesis (5) . Although porphyrins rise in Pb intoxication, the absolute depression of heme synthesis is inconsequential and cannot explain the fall in Hgb (5, 6) . Pb is known to have other effects on erythrocytes, including inhibition ofpyrimidine-5 '-nucleotidase activity (7), ineffective erythropoiesis (8) , and shortened red cell survival (9, 10) , but these also do not completely explain the effects of Pb on Hgb concentration.
Several studies suggest important subclinical, perhaps preclinical, defects in hematopoiesis. Grandjean et al. (11) described delayed blood regeneration capacity in Pb-workers who had normal Hgb concentrations prior to blood donation. That report led us to hypothesize that Pb may inhibit the synthesis of erythropoietin (EPO), a glycoprotein hormone which regulates both steady-state and accelerated erythrocyte production. More than 90% of EPO is produced in the proximal renal tubule (12, 13) where Pb accumulates; the remainder is produced in the liver. Indeed, we previously demonstrated that EPO is significandy depressed among pregnant women with moderately elevated BPbs (14) .
Hu et al. (15) subsequently described a highly significant negative association between tibia (and patella) bone Pb concentration and Hgb among 119 nonanemic men from the Carpenters' Union; yet no association between BPb and Hgb was found. This report suggests that bone Pb may be a more important marker of ongoing Pb toxicity than BPb. The authors suggested that the observed associations may reflect inhibition of hematopoiesis through depression of EPO, with bone Pb serving as a proxy for kidney Pb (15) .
As part of a long-term prospective study of environmental Pb exposure during infancy and childhood (16) (17) (18) , we examined the associations between BPb and EPO at ages 4.5, 6.5, and 9.5 years. We found that children with elevated BPbs maintain normal Hgb, but require hyperproduction of EPO to do so. Our working hypothesis is that children with moderately elevated BPbs have shortened red cell survival, a phenomenon previously described only in children with Pb encephalopathy (9) and in Pb workers (10) .
Methods
This study was conducted in two towns in Kosovo, Yugoslavia: Kosovska Mitrovica (K. Mitrovica), the site of a Pb mine, smelter, refinery, and battery plant; and Pristina, a relatively nonexposed town 25 miles to the south. Children were selected for follow-up from a previous prospective study of 1,502 pregnant women residing in these towns. Pregnancy outcomes (19, 20) and childhood developmental outcomes have been previously described (16) (17) (18) .
Subjects. In brief, 706 mother-infant pairs from the pregnancy study were invited to participate in a follow-up study involving repeated visits at 6-month intervals. Of these, the parents of 541 consented and brought their children to at least one visit. Of those who consented, 311 (53.5%), 267 (49.4%), and 260 (48.1%) participated in the visits at ages 4.5, 6.5, and 9.5 years, respectively. For the present study, whole blood for BPb and Hgb was available for 272, 201, and 234 children at each of these ages, respectively; sera for EPO analyses were available for 211, 178, and 234 children, respectively.
Laboratory analyses. At mid-pregnancy, delivery, and at each 6-month follow-up visit, venous blood samples were taken for the measurement of BPb (21) , erythrocyte protoporphyrin [EP (24] , and Hgb. At each visit, additional sera were obtained and frozen immediately to create a serum bank, from which the current study is derived. Whole blood and serum samples were stored at 40C and -20°C, respectively, and appropriately transported to Columbia University where all assays were performed. The laboratory participates in the BPb and EP quality control program of the Centers for Disease Control. During the study period relevant to this analysis, agreements with the quality control values for BPb and EP, measured by intradass correlation coefficients, were both 0.99.
All available sera from the visits at ages 4.5, 6.5, and 9.5 years were analyzed in duplicate for EPO using a commercially available enzyme immunoassay (23) . In our laboratory, the limit of detection of the assay was 0.6 mIU/ml, and the coefficient of variation for duplicate measures was 9.8%, 8.3%, and 7.9%, respectively, at ages 4.5, 6.5, and 9.5 years.
Statistical analysis. The association between BPb and EPO was examined using regression methods. Because the distributions of EPO and BPb are skewed, logarithmic transformations were used for these variables. All analyses were performed using SAS version 6.12 (SAS Institute, Cary, NC). First, we evaluated the association between BPb and EPO at each age using linear regression analysis, controlling for concurrent Hgb concentration. Concurrent Hgb was always controlled because it is the most important predictor of EPO (13) . Second, we combined data from all ages and used repeated measures analysis (described below) to determine whether the associations between BPb and EPO, controlling for Hgb, changed over time.
The repeated measures analysis was based on 614 observations from 346 children with EPO, BPb, and Hgb measurements available for at least one time point (i.e., ages 4.5, 6.5, or 9.5 years). 
concentrations ranged from 2.4 to 40.4, 1.6 to 27.1, and 2.1 to 24.0 mU/ml, respectively. In Pristina, the mean EPO rose steadily over time from 5.6 to 8.8 mIU/ml (Fig. IC) . In K. Mitrovica, EPO rose between ages 4.6 and 6.5 years (from 7.8 to 9.7 mIU/ml) and then declined to 8.8 mIU/ml at age 9.5 years. The differences in EPO between towns were statistically significant at ages 4.5 (p = 0.0017) and 6.5 years (p = 0.02), with higher concentrations in K. Mitrovica.
Because Hgb is a strong determinant of EPO (13) , EPO was examined within Hgb strata for each age (Fig. 2) . Few children were anemic; there were 9, 1, and 1 children with Hgb below 11.0 g/dl at ages 4.5, 6.5, and 9.5 years, respectively. Within each Hgb stratum, EPO was higher in K. Mitrovica except at age 9.5 years, when the town differences diminished.
Associations between BPb and EPO, adjusted for Hgb and specific to each age, are shown in Table 1 . As expected in each of these models, Hgb was inversely and significandy associated with EPO. Statistically significant associations between BPb and EPO were found at ages 4.5 and 6.5 years; however, the magnitude of the association at age 6.5 was approximately halfthat at age 4.5. At age 9.5 years, the association was not statistically significant and was approximately an order of magnitude less than that at age 4.5.
Results of a regression analysis using repeated measures were similar. At ages 4.5 and 6.5 years, BPb was significantly and positively associated with EPO (p<0.0001 and p = 0.0007, respectively). This association diminished at 9.5 years of age. Indeed, the difference in the association between BPb and EPO at ages 4.5 and 9.5 years was statistically significant (p = 0.0006), while that between ages 4.5 and 6.5 was not. To test whether the association between BPb and EPO varied by Hgb, we repeated all analyses indcluding the appropriate interaction terms.
Based on this GEE model and after adjustment for Hgb, a significant interaction between BPb and age was found, indicating that the association between EPO and BPb varied by age (see Appendix). Further analyses found no interaction ofHgb and age. (14) found depressed serum EPO in women whose BPbs were substantially lower than the children in the current study. Thus, it appears more likely that the dedine in slope with age reflects a gradually decreasing ability to produce EPO. We also note, however, that the relationship between BPb and EPO is subtle because the observed serum EPO concentrations in this cohort were nearly all within the published age-related norms (25) . A review by Aub et al. in 1925 (1) concluded that although severe plumbism in man may involve "bone marrow failure," anemia was initially due to accelerated destruction of circulating red cells, a phenomenon first suggested in the 19th century (26, 27) . Supportive mechanistic studies revealed that patients with plumbism had red cell membrane defects which were associated with increased red cell mechanical fragility and decreased osmotic fragility (1). In animals, Pb-induced anemia was found to be reversed by removal of the spleen (28), which removes abnormal and/or aged red cells from circulation.
Numerous animal studies indicate that a two-step sequence of events is involved in Pb-induced anemia. For example, in rabbits acutely poisoned with Pb, peripheral red cell destruction was followed by active bone marrow hyperplasia (29) , indicative (in retrospect) of active renal EPO production. With time, however, rabbit bone marrow activity declined, suggesting either failure of erythropoietic stem cells, a decline in renal EPO production, or both. The same temporal sequence has been described in children. Leikin and Eng (9) described shortened 51Cr red cell survival in children with BPbs of 60-238 pg/dl. Among their patients whose Pb exposure was short in duration, turnover of 59Fe in plasma was abnormally high, indicative ofbone marrow hyperactivity; in those with long-term Pb exposure iron turnover was depressed, consistent with marrow hypoactivity.
Our finding that BPb was positively associated with EPO in children at ages 4.5 and 6.5 years is consistent with the first pathophysiologic step, i.e., peripheral red cell destruction, renal EPO production, and bone marrow hyperactivity. Our 
